Zion Market Research Global Drug Delivery Technology Market, 2016–2024 | Page 3

Drug Delivery Technology Market
minimum invasive surgeries. In addition, the home care & self-administration and
increasing need for generic drugs and biosimilars are few other factors driving the market
growth. However, patent expiry, the risk of needle-stick injuries, regulatory obstacles, and
side-effects associated with drugs are some factors that may restrict the growth of the
market.
Global Drug Delivery Technology Market: Segmentation
The global drug delivery technology market can be segmented on the basis of end-user,
route of administration, and region. The end-user segment of the market is classified into
home care settings, hospitals, diagnostic centers, ambulatory surgical centers, and other
facilities of use. The route of administration segment of the market is diversified into ocular
drug delivery, pulmonary drug delivery, injectable drug delivery, oral drug delivery,
implantable drug delivery, topical drug delivery, parenteral route, transmucosal drug
delivery, and nasal drug delivery. The pulmonary drug delivery segment of the market is
divided into dry powder inhaler, metered dose inhaler, and nebulizers. The implantable
drug delivery segment of the market is classified into passive implantable drug delivery and
active implantable drug delivery. The parenteral route segment of the drug delivery
technology market is sub-segmented into intra-arteria, intramuscular, subcutaneous route,
and intravenous. Geographically, the market is categorized into Europe, North America,
Asia-Pacific, Latin America, and the Middle East & Africa.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/drug-delivery-technology-market